'Brutal' type of fasting diet better for weight loss than any other
Alternate day fasting involves a 24-hour fast on alternate days and has become more popular in recent years. Other intermittent fasting approaches to dieting have also grown in popularity, including time restricted eating, where people only eat for a certain number of hours in the day, such at the 16:8 diet involving a 16-hour fasting period followed by an eight-hour eating; and whole day fasting, which includes the 5:2 diet involving five days of eating and two days of fasting periods.
Researchers from Scotland, the US, Canada and Germany wanted to compare fasting methods to continuous energy restriction diets by looking at all of the available evidence. They examined data from 99 studies involving more than 6,500 people.
READ MORE: 'Moral obligation' to save special Surrey building as £200k of extra repair work approved
READ MORE: The gorgeous Surrey lido in the grounds of a rustic hotel at the base of a famous hill
People involved in the studies had an average body mass index (BMI) of 31 and almost nine in 10 (89%) had pre-existing health conditions. The research team found that both intermittent fasting diets and calorie restricted diets led to weight loss.
But compared with continuous energy restriction, alternate day fasting was the only strategy to show benefit in body weight reduction, with people on this diet losing 1.29kg more, according to the study, which has been published in The BMJ. The authors said that alternate day fasting showed a 'trivial' reduction in body weight compared with both time restricted eating and whole day fasting
'Minor differences were noted between some intermittent fasting diets and continuous energy restriction, with some benefit for an alternate day fasting strategy with weight loss in shorter duration trials,' the authors wrote. 'All intermittent fasting strategies and continuous energy restriction diets showed a reduction in body weight when compared with an ad-libitum diet
'Of three intermittent fasting diets (ie, alternate day fasting, time restricted eating, and whole day fasting), alternate day fasting showed benefit in body weight reduction compared with continuous energy restriction.'
Around 29% of adults in the UK are obese. Last week the NHS ' top doctor said that weight loss jabs could be as transformative as statins.
Later this month GPs in England will be allowed to prescribe mounjaro, also known as tirzepatide, for the first time. Patients previously needed to access the drugs through a special weight loss service.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
New Bedford mosquito sample tests positive for West Nile virus again. What to know.
West Nile virus has been detected in a mosquito sample in New Bedford for the second time in recent weeks. The Massachusetts Department of Public Health notified local health officials about the finding, which was in a primarily bird-biting mosquito near Oak Grove Cemetery on Parker Street, according to a community announcement. The risk level for West Nile virus in New Bedford, Fairhaven and Acushnet is moderate. Preventative measures include wearing mosquito repellent between dusk and dawn, wearing long sleeves and pants during those hours, using mosquito netting on baby carriages and playpens, and emptying standing water around homes twice weekly. The Bristol County Mosquito Project conducted targeted ground-spraying Aug. 14 in the Oak Grove Cemetery area. This spraying supplements the county's normal weekly ground-spraying, which occurs seasonally from early June through September and targets parks and other locations that host large public events. Weekly sprayings take place every Thursday during the summer between 2 a.m. and sunrise in locations around Buttonwood Park, Brooklawn Park, Fort Taber, Hazelwood Park, Riverside Park, Clasky Common Park, Ashley Park, Wing's Court, Custom House Square and other parts of downtown. Residents near targeted areas may want to close their windows in the evenings before spraying. In the event of inclement weather, spraying will be moved to early Friday morning. The annual monitoring program involves crews placing traps and collecting specimens to monitor the mosquito population throughout the summer. It also helps track whether any mosquitoes are carrying Eastern equine encephalitis or West Nile virus. West Nile virus is a mosquito-borne virus that can cause illness ranging from a mild fever to more serious disease. It is most commonly spread to people through the bite of an infected mosquito. Positive mosquito samples for West Nile are not uncommon in the summer months and have been found in cities and towns across the state in recent weeks. The New Bedford Health Department recommends several precautionary measures to help protect against mosquito bites: Be aware of peak mosquito hours: Mosquitoes are most active from dusk to dawn. Consider rescheduling outdoor activities during these times or take extra precautions with repellent and protective clothing, especially if you spend a lot of time outdoors. Clothing can help reduce mosquito bites: Wearing long sleeves, long pants and socks when outdoors can help keep mosquitoes away from your skin, even though it may be challenging in hot weather. Apply insect repellent when outdoors: Use a repellent with DEET, permethrin, picaridin, IR3535 or oil of lemon eucalyptus according to the product label instructions. DEET products should not be used on infants under 2 months of age and should be used in concentrations of 30% or less on older children. Oil of lemon eucalyptus should not be used on children under 3 years of age. Permethrin products are intended for use on items such as clothing, shoes, bed nets and camping gear and should not be applied to skin. Drain standing water: Mosquitoes lay eggs in standing water. Limit breeding sites around your home by draining or removing items that hold water. Check rain gutters and drains, empty unused flowerpots and wading pools, and change water in birdbaths frequently. Install or repair screens: Some mosquitoes can enter homes. Keep them outside by ensuring tight-fitting screens on all windows and doors. For more information and the state's risk-level map, visit This story was created by reporter Beth McDermott, bmcdermott1@ with the assistance of Artificial Intelligence (AI). Journalists were involved in every step of the information gathering, review, editing and publishing process. Learn more at This article originally appeared on Standard-Times: West Nile virus detected in mosquito sample in New Bedford Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment
By Jacob Gronholt-Pedersen COPENHAGEN, DENMARK (Reuters) -Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver condition, positive news for the drugmaker that lost more than one-third of its market value in recent weeks. Novo's shares rose as much as 5% at opening and were trading 3.5% higher by 0711 GMT. Three weeks ago, investors wiped $70 billion off its market value, after Novo - which became Europe's most valuable listed company following the launch of Wegovy in 2021 - issued a profit warning and named a company veteran as new CEO. On Friday, the U.S. Food and Drug Administration granted accelerated approval for Wegovy to treat metabolic dysfunction-associated steatohepatitis, or MASH, making it the first GLP-1 class therapy cleared for the progressive liver condition that affects around 5% of adults in the United States. Rival Eli Lilly has published encouraging MASH data in a mid-stage trial with tirzepatide - the active ingredient in its popular diabetes drug Mounjaro and weight-loss treatment Zepbound. "It is expected that this market exclusivity will only last for a transitional phase before Eli Lilly also launches a product on the market," said Nordnet analyst Per Hansen. Novo has also applied this year for approval in Europe and Japan. Its shares have lost more than two-thirds of their value since June last year, amid concerns that the Danish drugmaker is losing ground in the obesity drug race it started to rival Eli Lilly and "compounded" copycat drugs. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Trending tickers: Novo Nordisk, Palo Alto Networks, Walmart, Soho House and Nio
Novo Nordisk ( NVO) Copenhagen-listed shares in pharmaceuticals giant Novo Nordisk ( rose nearly 4% on Monday morning, after the company announced that its blockbuster weight-loss drug Wegovy had been approved in the US to treat a form of liver disease. Novo ( said in an announcement on Friday that the US Food and Drug Administration (FDA) had approved Wegovy for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis, in combination with a reduced calorie diet and increased physical activity. Read more: Markets mixed as Zelensky and European leaders head to Washington for war talks The company said that accelerated approval is based on part one of a trial, in which Wegovy, demonstrated a statistically significant and superior improvement in liver fibrosis with no worsening of steatohepatitis, as well as resolution of steatohepatitis with no worsening of liver fibrosis compared to a placebo. The news offers a boost to Novo Nordisk ( which has been facing increasing competition in the weight-loss market, with shares in company currently down nearly 46% year-to-date. Martin Holst Lange, executive vice president, chief scientific officer and head of research and development at Novo ( said: "Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide." Palo Alto Networks (PANW) Shares in Palo Alto Networks (PANW) hovered just above the flatline in pre-market trading on Monday morning, ahead of the US cybersecurity company reporting its fourth quarter earnings later in the day. The company had guided to revenue for the quarter in the range of $2.49bn (£1.83bn) to $2.51bn, which would represent year-over-year growth of between 14% and 15%. Shares in the Palo Alto (PANW) came under pressure following the release of its third quarter earnings in May, as the results failed to impress investors. The cybersecurity company's third quarter revenue came in at $2.3bn, just above expectations, while adjusted earnings per share (EPS) were $0.80. Walmart (WMT) Shares in Walmart (WMT) were also trending on Monday, ahead of the company reporting its second quarter earnings on Thursday. Walmart's results are closely watched by investors as it is the largest retailer in the US, so it is considered to act as a barometer for consumer sentiment. The stock is up nearly 11% year-to-date but edged lower after Walmart (WMT) released a mixed set of first quarter results in May. Walmart (WMT) posted first quarter revenue of $165.5bn, which was up 2.5% from the same period last year, though this missed Wall Street expectations of $166.02bn. Adjusted earnings per share grew 1.7% year over year to $0.61, beating estimates of $0.58. US same-store sales also beat expectations with a 4.5% increase, led by health and wellness, and groceries. Stocks: Create your watchlist and portfolio John David Rainey, chief financial officer of Walmart (WMT), said in the earnings release that the company had decided to hold off on providing a specific range of guidance for operating income growth and earnings per share for the second quarter, given the "dynamic nature of the backdrop". Walmart (WMT) did guide to net sales growth of 3.5% to 4.5% for the quarter, based on the $167.8bn it reported a year ago. AJ Bell's (AJB.L) investment director Russ Mould and head of financial analysis Danni Hewson said that analysts expect a headline figure for net sales of $174bn. "That turns into a consensus analysts' forecasts for [net profit in] the second quarter of $5.8bn, and a headline earnings per share (EPS) figure of $0.72, up from $0.67 a year ago," they said. Soho House (SHCO) Shares in Soho House (SHCO) surged 13% in pre-market trading on Monday, following reports that the members' club was nearing a deal to go private. The Wall Street Journal reported on Sunday that a group of investors led by MCR Hotels was nearing a deal to take Soho House private. Read more: Stocks that are trending today They are reportedly expected to pay around $9 per share for the company's outstanding stock, with the deal valuing the company at $1.8bn. A spokeperson for Soho House (SHCO) had not responded to Yahoo Finance UK's request for comment at the time of writing. Nio ( NIO) Shares in Chinese electric vehicle company Nio ( jumped nearly 7% on Monday, after announcing it expansion into three new markets. Nio ( said in announcement on Monday that it planned to enter Singapore, Uzbekistan and Costa Rica in 2025 and 2026. Chris Chen, head of global business development at Nio ( said: "To accelerate our entry into diverse global markets, Nio is partnering with experienced players who have deep local expertise and extensive distributor networks. "They will help us introduce our high-quality smart electric vehicles to new markets more efficiently." Read more: Bank of England cuts gilt holdings by £32.5bn in second quarter The most popular stocks and funds investors bought in July UK job market continues to weaken as vacancies fall
